市場調查報告書

全球過敏症狀緩和用眼科用藥市場:成長,趨勢,及預測(2020年∼2025年)

Allergy Relieving Eye Drops Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 921869
出版日期 內容資訊 英文 111 Pages
商品交期: 2-3個工作天內
價格
全球過敏症狀緩和用眼科用藥市場:成長,趨勢,及預測(2020年∼2025年) Allergy Relieving Eye Drops Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年01月01日內容資訊: 英文 111 Pages
簡介

由於近來眼部過敏的高流行,對過敏性眼藥水的需求正在推動全球過敏症狀眼藥水市場的增長。特別是抗組胺藥在預測期內預計將以高速度增長。此外,眼過敏藥物的研發擴大將為市場帶來比現有產品更有效的創新藥物,並將刺激包括刺激性,頭痛等在內的市場增長。但副作用可能會阻礙市場增長。

本報告提供全球過敏症狀緩和用眼科用藥市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,各藥物類別·類型·地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 眼科疾病的發生率上升
    • 眼過敏藥的研究開發擴大
  • 市場阻礙因素
    • 眼科用藥的副作用
  • 波特的五力分析

第5章 市場區隔

  • 各藥物類別
    • 抗組織胺藥
    • 非類固醇系抗發炎藥
    • 血管收縮藥
    • 其他
  • 各類型
    • 季節性及全年性過敏性結膜炎
    • 春季粘膜炎
    • 特異反應性性角結膜炎
    • 巨大乳頭結膜炎
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Allergan Plc
    • Johnson & Johnson
    • Pfizer
    • F. Hoffmann-La Roche Ltd
    • Novartis AG
    • Bausch Health Companies Inc
    • Regeneron Pharmaceuticals
    • Santen Pharmaceutical Co

第7章 市場機會及今後趨勢

目錄
Product Code: 67414

Market Overview

Eye Allergy has been increasing in recent years. According to a report by BioMed Research International 2017, the overall prevalence of ocular allergy among school children in Shanghai, China is about 28%. Also, it has been observed that around 15% to 20%of the US population suffers from an ocular allergy. This high prevalence of ocular allergy has increased the demand for allergy eye drops and hence, this factor has acted as a driving factor helping this market grow.

Furthermore, the increasing research and development in eye allergy medication have also brought new innovative medications to the market which are more effective than their predecessors. This factor has also helped this market grow. However, side effects from allergy relieving eye drops, including irritation, headache, and others, have been restraining the growth of this market.

Scope of the Report

An allergic reaction occurs when a person's immune system reacts to an allergen in the environment, either indoors or outdoors. An allergen is any substance that causes allergy symptoms in sensitive individuals. Allergy relieving eye drops are used to prevent and treat itching of the eyes caused by allergies.

In the report, a detailed analysis of the allergy relieving eye drops market is provided. The market is evaluated by collating revenues generated across segments, categorized by drug class, type, and geography.

Key Market Trends

Antihistamines are Expected to Register a High Growth Rate

Antihistamines block histamine release from histamine-1 receptors and are used to treat the symptoms of an allergic reaction such as edema (swelling), itch, inflammation (redness), and watery eyes.

Eye edema is a very common occurrence. It is primarily caused by Unhealthy cornea prior to surgery. Subsequently, any procedure within the eye (such as cataract, glaucoma or retinal surgery) can cause the cornea to fail and develop edema. As antihistamines effectively treat edema, the market is expected to increase in the forecast period.

North America is expected to dominate the market

North America includes the United States (US), Canada, and Mexico. The United States and Canada have developed healthcare systems and also spend huge amounts in research and development fo the same. As a result, most of the global treatments are available in this region.

According to a Yanqing Feng et al, published in BioMed Research International 2017, among the US households, 34% prevalence of Ocular Allergy symptoms were reported in children. This high prevalence has increased the demands for ocular allergy medications, which is helping the growth of the Allergy Relieving Eye Drops market.

Competitive Landscape

The majority of the allergy relieving eye drops are being manufactured by the global key players. Market leaders with more funds for research and a better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing the emergence of some small players due to the rise of awareness. This has also helped the market growth.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in Incidence of Ocular Diseases
    • 4.2.2 Increasing Research and Development in Eye Allergy Medication
  • 4.3 Market Restraints
    • 4.3.1 Side Effects from Eye Drops
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Drug Class
    • 5.1.1 Antihistamines
    • 5.1.2 Non-steroidal anti-Inflammatory Drugs
    • 5.1.3 Vasoconstrictors
    • 5.1.4 Others
  • 5.2 By Type
    • 5.2.1 Seasonal and Perennial Allergic Conjunctivitis
    • 5.2.2 Vernal Keratoconjunctivitis
    • 5.2.3 Atopic Keratoconjunctivitis
    • 5.2.4 Giant Papillary Conjunctivitis
    • 5.2.5 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Allergan Plc
    • 6.1.2 Johnson & Johnson
    • 6.1.3 Pfizer
    • 6.1.4 F. Hoffmann-La Roche Ltd
    • 6.1.5 Novartis AG
    • 6.1.6 Bausch Health Companies Inc
    • 6.1.7 Regeneron Pharmaceuticals
    • 6.1.8 Santen Pharmaceutical Co

7 MARKET OPPORTUNITIES AND FUTURE TRENDS